Pharmaceutical giant Merck said it plans to acquire privately-held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that’s shown striking results in hospitalized patients with Covid-19. Dr. Yang Liu, founder, CEO and chief scientific officer of…
The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly’s arthritis drug baricitinib, in combination with Gilead Sciences’ remdesivir, to treat Covid-19 patients. On Thursday, a WHO panel advised doctors against using remdesivir as a…
New lockdowns and tough social restrictions were reintroduced across a number of European countries in an effort to contain the second wave. Sweden appears to be changing tack and implementing stricter measures as a second wave of infections takes hold…
Wright Lassiter, CEO of the Henry Ford Health System in Detroit, joins “Squawk on the Street” to discuss how the hospital system is handling the influx of coronavirus patients. For access to live and exclusive video from CNBC subscribe to…
President Donald Trump left Walter Reed National Military Medical Center on Monday to return to the White House, where he will continue to be treated for the coronavirus even as he looks to restart his reelection campaign. Shortly before his…
CNBC’s Meg Tirrell takes a look at the treatments and experimental medicines President Trump is receiving for what experts are saying is a ‘severe’ case of Covid-19. For access to live and exclusive video from CNBC subscribe to CNBC PRO:…
